DYNAMIC CHANGES OF CHEMOKINE CXCL-10 (IP-10) IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS
https://doi.org/10.15789/1563-0625-2016-3-279-286
Abstract
CXCL10 (IP-10) chemokine is one of additional humoral markers applied along with determination of antigen-induced IFNγ for diagnosis of latent tuberculosis infection in humans. Dynamics of the IP-10 changes and its prognostic value in planning treatment for various forms of tuberculosis is a scarcely studied problem, especially, in children and adolescents. Present study has revealed an increase in spontaneous and antigen-induced IP-10 production in children and adolescents with overt tuberculosis, when compared with latent course of tuberculosis, followed by its significant reduction in cases of successful chemotherapy of tuberculosis. Such dynamics was not evident in destructive forms of tuberculosis manifesting as torpid and progressive infection.
About the Authors
M. M. Averbakh (Jr)
Central Research Institute for Tuberculosis, Moscow, Russian Federation
Russian Federation
Russian Federation
107564, Russian Federation, Moscow, Yausa Allee, 2. Phone: 7 (499) 785-90-72. Fax: 7 (499) 785-91-08 PhD, MD (Medicine), Professor, Main Research Associate, Department of Immunology
L. V. Panova
Central Research Institute for Tuberculosis, Moscow, Russian Federation
Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, Leading Research Associate, Pediatric Department
M. F. Gubkina
Central Research Institute for Tuberculosis, Moscow, Russian Federation
Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, Leading Research Associate
References
1. Al-Attyan R., Mustafa A.S. Characterization of Human Cellular Immune Responses to Novel Mycobacterium tuberculosis Antigens Encoded by Genomic Regions Absent in Mycobacterium bovis BCG. Infect Immun., 2008, Vol. 76, pp. 4190-4198.
2. Alsleben N., Ruhwald M., Rüssmann H., Marx F.M., Wahn U., Magdorf K. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand. J. Infect. Dis., 2012, Vol. 44, no. 4, pp. 256-262.
3. Djoba Siawaya J.F., Beyers N., van Helden P., Walzl G. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clinical and Experimental Immunology, 2009, Vol. 156, pp. 69-77.
4. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol., 1997, Vol. 61, pp. 246-257.
5. Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol., 2011, Vol. 89, pp. 207-215.
6. Hong J.Y., Jung G.S., Kim H., Kim Y.M., Lee H.J., Cho S.N., Kim S.K., Chang J., Kang Y.A. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. Int. J. Infect. Dis., 2012, Vol. 16, no. 12, e855-859.
7. Hong J.Y., Lee H.J., Kim S.Y., Chung K.S., Kim E.Y., Jung J.Y., Park M. S., Kim Y.S., Kim S.K., Chang J., Cho S.N., Kang Y.A. Efficacy of IP-10 as a biomarker for monitoring tuberculosis treatment. Journal of Infection, 2014, Vol. 68, pp. 252-258.
8. Lighter J., Rigaud M., Huie M., Peng C.H., Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int. J. Tuberc. Lung Dis., 2009, Vol. 13, pp. 731-736.
9. Ruhwald M., Bjerregaard-Andersen M., Rabna P., Kofoed K., Eugen-Olsen J., Ravn P. IP-10/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB77. Microbes Infect., 2007, Vol. 9, pp. 806-812.
10. Ruhwald M., Bodmer T., Maier C., JepsenM., HaalandM.B., Eugen-Olsen J., Ravn P. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J., 2008, Vol. 32, pp. 1607-1615.
11. Ruhwald M., Aabye M.G., Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev. Mol. Diagn., 2012, Vol. 12, pp. 175-187.
12. Tang N.L., Fan H.P., Chang K.C., Ching J.K., Kong K.P., Yew W.W., Kam K.M., Leung C.C., Tam C.M., Blackwell J., Chan C.Y. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin. Chim. Acta, 2009, Vol. 406, pp. 98-102.
13. Yassin M.A., Petrucci R., Garie K.T. Can interferon-g or interferon-g-inducedprotein-10 differentiate tuberculosis infection and disease in children of high endemic areas. PLoS One, 2011, Vol. 6, e23733.
Review
For citations:
Averbakh (Jr) M.M., Panova L.V., Gubkina M.F. DYNAMIC CHANGES OF CHEMOKINE CXCL-10 (IP-10) IN CHILDREN AND ADOLESCENTS WITH DIFFERENT FORMS OF PULMONARY TUBERCULOSIS. Medical Immunology (Russia). 2016;18(3):279-286. (In Russ.) https://doi.org/10.15789/1563-0625-2016-3-279-286
Views:
816
Email this article 